Ltd. Pineo Medical Ecosystem

Tbilisi 0114

1 studies enrolling now · 4 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer, Generalized Myasthenia Gravis, Multiple Sclerosis (MS), Relapsing-remitting Multiple Sclerosis (RRMS)

Studies at this site

• Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad) — Recruiting now
• Comparison Between ABP 692 and Ocrevus® (Ocrelizumab) — Running, not enrolling
• Study With Various Immunotherapy Treatments in Participants With Lung Cancer — Running, not enrolling
• Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS) — Completed